Optima: Optimal personalised treatment of early breast cancer using multi-parameter analysis, an international randomized trial of tumor gene expression test-directed chemotherapy treatment in a largely node-positive population.

Stein, RC, Makris, A, MacPherson, IR et al. (17 more authors) (2021) Optima: Optimal personalised treatment of early breast cancer using multi-parameter analysis, an international randomized trial of tumor gene expression test-directed chemotherapy treatment in a largely node-positive population. In: 2021 ASCO Annual Meeting, 04-08 Jun 2021, Virtual.

Metadata

Authors/Creators:
  • Stein, RC
  • Makris, A
  • MacPherson, IR
  • Hughes-Davies, L
  • Marshall, A
  • Dotchin, G
  • Cameron, DA
  • Kiely, BE
  • Tsang, J
  • Naume, B
  • Rea, DW
  • Ohnstad, HO
  • Hall, PS
  • McIntosh, S
  • Shinkins, B ORCID logo https://orcid.org/0000-0001-5350-1018
  • McCabe, C
  • Morgan, A
  • Bartlett, J
  • Dunn, J
  • OPTIMA Trial Management Group
Dates:
  • Published: 20 May 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds) > Academic Unit of Health Economics (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 08 Dec 2021 14:41
Last Modified: 08 Dec 2021 14:41
Status: Published
Identification Number: https://doi.org/10.1200/JCO.2021.39.15_suppl.TPS599
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics